A 73-year-old woman admitted with mild, spontaneously resolving upper GI hemorrhage, not requiring transfusion, had a history of significant aspirin ingestion over 4 months for rheumatoid arthritis pain. Endoscopy confirmed a duodenal ulcer, and biopsy was positive for H. pylori. What is the recommended next step in managing this duodenal ulcer?
Palmar erythema is seen in all of the following conditions except?
Portal hypertension is defined as hepatic venous pressure gradient more than:
Venoocclusive disease is seen in all except?
Acalculous cholecystitis can be seen in all of the following conditions except?
Abdominal pain, fat malabsorption, and frothy stools suggest which of the following conditions?
Which investigation is considered the gold standard for diagnosing GERD?
Which of the following statements regarding gluten-sensitive enteropathy is not true?
A 65-year-old woman with a history of Hashimoto's thyroiditis presented with symptoms of malabsorption. Following evaluation, she was diagnosed with atrophic gastritis. Which of the following is NOT a feature of this patient's condition?
Which of the following endoscopic findings is suggestive of Crohn's disease in a patient with chronic diarrhea?
Explanation: **Explanation:** The management of peptic ulcer disease (PUD) focuses on addressing the underlying etiology to promote healing and prevent recurrence [1]. In this patient, two major risk factors are present: **chronic NSAID (Aspirin) use** and **H. pylori infection** [1]. **1. Why Triple Therapy is Correct:** The presence of *H. pylori* is a definitive indication for eradication therapy, regardless of NSAID use [1]. Eradicating the organism significantly reduces the rate of ulcer recurrence and complications [1]. Standard **Triple Therapy** (Proton Pump Inhibitor + Clarithromycin + Amoxicillin/Metronidazole) is the first-line treatment. Even though aspirin contributed to the ulcer [1], failing to treat the infection leaves the patient at high risk for future bleeds. **2. Why Incorrect Options are Wrong:** * **H2 Blockers (A):** While they reduce acid, they are less potent than PPIs and do not address the *H. pylori* infection. They are no longer the standard of care for active ulcer healing when more effective options exist. * **Bipolar Electrocautery (B) & Photocoagulation (D):** These are **endoscopic hemostatic interventions**. They are indicated for *active* bleeding, visible vessels, or adherent clots (high-risk Forrest classification). Since the patient’s hemorrhage was mild and resolved spontaneously without the need for transfusion, invasive mechanical or thermal therapy is not indicated. **Clinical Pearls for NEET-PG:** * **Most common cause of PUD:** *H. pylori* (Duodenal > Gastric). * **Second most common cause:** NSAIDs (Gastric > Duodenal). * **Investigation of choice for PUD:** Upper GI Endoscopy (UGIE). * **Test of Cure:** Always perform a urea breath test or stool antigen test 4 weeks after completing therapy to confirm eradication [1]. * **NSAID management:** If possible, NSAIDs should be discontinued. If mandatory, co-prescription with a PPI is required for prophylaxis.
Explanation: **Explanation:** Palmar erythema is a clinical sign characterized by a symmetrical, mottled reddening of the palms, specifically over the thenar and hypothenar eminences. The underlying pathophysiology is primarily related to **hyperdynamic circulation** and **increased levels of circulating estrogen**, which lead to capillary dilatation. **Why Anemia is the Correct Answer:** Anemia is characterized by **pallor** of the palmar creases [1] and conjunctiva [1] due to reduced hemoglobin levels. While severe anemia can cause a hyperdynamic state, it does not typically manifest as palmar erythema. Therefore, it is the "except" in this list. **Analysis of Other Options:** * **Pregnancy (Option A):** High levels of endogenous estrogen during pregnancy cause increased vascularity and capillary dilatation, making palmar erythema a common physiological finding (seen in ~60-70% of pregnancies). * **Cirrhosis (Option B):** This is the most classic association. In chronic liver disease, the liver's ability to metabolize estrogen is impaired. Elevated estrogen levels and increased nitric oxide production lead to peripheral vasodilation and palmar erythema. * **Wilson Disease (Option D):** As a cause of chronic hepatitis and eventually cirrhosis, Wilson disease leads to palmar erythema via the same mechanism of hepatic insufficiency and altered hormone metabolism. **NEET-PG High-Yield Pearls:** * **Distribution:** Palmar erythema typically spares the central portion of the palm. * **Other Causes:** Thyrotoxicosis (due to increased cardiac output), Rheumatoid Arthritis (RA), and Chronic Febrile illnesses. * **Liver Signs:** Often co-exists with **Spider Angiomata** (also estrogen-dependent). * **Clinical Note:** It is not specific to liver disease but serves as a marker for altered sex hormone metabolism or systemic vasodilation.
Explanation: **Explanation:** Portal hypertension is defined by an increase in the **Hepatic Venous Pressure Gradient (HVPG)**. The HVPG is the difference between the wedged hepatic venous pressure (representing sinusoidal pressure) and the free hepatic venous pressure (representing systemic venous pressure) [1]. 1. **Why 5 mm Hg is correct:** The normal HVPG ranges between **1 to 5 mm Hg** [1]. Portal hypertension is clinically defined as an HVPG **>5 mm Hg**. This represents the earliest hemodynamic threshold where portal pressures exceed the normal physiological range. 2. **Analysis of Incorrect Options:** * **1 mm Hg (Option A):** This is within the lower limit of the normal range and does not constitute hypertension. * **10 mm Hg (Option C):** This is the threshold for **Clinically Significant Portal Hypertension (CSPH)** [1]. At this level, complications like esophageal varices and ascites begin to develop. * **20 mm Hg (Option D):** This is a high-risk threshold associated with a significantly increased risk of active variceal bleeding and failure to control bleeding despite treatment. **High-Yield Clinical Pearls for NEET-PG:** * **HVPG >5 mm Hg:** Definition of Portal Hypertension [1]. * **HVPG ≥10 mm Hg:** Clinically Significant Portal Hypertension (CSPH); predicts the development of varices [1]. * **HVPG ≥12 mm Hg:** Threshold for **variceal rupture/bleeding**. * **Gold Standard:** HVPG measurement via the transjugular route is the gold standard for assessing portal pressure, as direct portal vein catheterization is invasive and risky [1].
Explanation: **Explanation:** **Veno-occlusive disease (VOD)**, now more commonly referred to as **Sinusoidal Obstruction Syndrome (SOS)**, involves the non-thrombotic obstruction of hepatic venules and sinusoids by subendothelial swelling and collagen deposition [1]. **Why Mushroom Poisoning is the Correct Answer:** Mushroom poisoning, specifically from *Amanita phalloides* (Death Cap), contains **amatoxins**. These toxins cause **massive centrilobular hepatic necrosis** (fulminant hepatic failure) rather than the vascular/sinusoidal obstruction seen in VOD [2]. While both lead to liver damage, the pathophysiological mechanism of mushroom poisoning is direct hepatocyte death, not venous outflow obstruction. **Analysis of Incorrect Options:** * **Bone Marrow Transplant (BMT):** This is the most common cause of VOD/SOS in modern clinical practice. It occurs due to the toxic effects of high-dose **pre-transplant conditioning regimens** (chemotherapy and total body irradiation) on the sinusoidal endothelial cells [1]. * **Bush Teas:** Historically, VOD was described in populations consuming "bush teas" containing **Pyrrolizidine alkaloids** (found in plants like *Crotalaria* and *Senecio*). These alkaloids are metabolized into toxic pyrroles that damage the sinusoidal lining. * **Cytosine Arabinoside (Ara-C):** This is a chemotherapeutic agent known to be associated with VOD, especially when used in high doses or in combination with other alkylating agents during induction or conditioning therapy [1]. **NEET-PG High-Yield Pearls:** * **Clinical Triad of VOD:** Painful hepatomegaly, jaundice, and fluid retention (weight gain/ascites). * **Diagnosis:** Primarily clinical (Modified Seattle Criteria or Baltimore Criteria). In contrast to Budd-Chiari, the large hepatic veins appear patent radiologically [1]. * **Key Histology:** Fibrous obliteration of small hepatic venules and congestion of sinusoids [1]. * **Drug of Choice:** **Defibrotide** is used for the treatment of severe hepatic VOD post-HSCT as it promotes fibrinolysis [1].
Explanation: **Explanation:** **Acalculous cholecystitis (AC)** is the inflammation of the gallbladder in the absence of gallstones. It typically occurs in critically ill patients due to gallbladder stasis and ischemia [1]. **Why Malaria is the Correct Answer:** While malaria (especially *P. falciparum*) can cause multi-organ dysfunction, it is **not** a recognized or typical cause of acalculous cholecystitis. Jaundice in malaria is primarily pre-hepatic (hemolysis) or due to malarial hepatitis (hepatocellular damage), rather than primary gallbladder inflammation. **Analysis of Other Options:** * **Dengue Hemorrhagic Fever:** AC is a well-documented complication of Dengue. It occurs due to increased vascular permeability leading to gallbladder wall edema and serous effusion, often seen during the critical phase. * **Leptospirosis:** This zoonosis can cause AC through direct bacterial invasion or systemic vasculitis. It is often part of the clinical spectrum in severe cases (Weil’s disease) alongside jaundice and renal failure. * **Enteric Fever (Typhoid):** *Salmonella typhi* can colonize the gallbladder. While it more commonly leads to a chronic carrier state in patients with stones, acute acalculous cholecystitis can occur during the second or third week of the illness due to lymphatic spread or direct invasion. **Clinical Pearls for NEET-PG:** * **Most common cause:** AC is most frequently seen in patients in the **ICU** (post-major surgery, severe trauma, burns, or prolonged TPN) [1]. * **Diagnosis:** **Ultrasonography** is the initial investigation of choice (look for wall thickening >4mm, pericholecystic fluid, and a positive sonographic Murphy’s sign). * **HIDA Scan:** This is the most sensitive imaging modality for AC if ultrasound is inconclusive. * **Other infectious causes:** HIV (CMV or Cryptosporidium), Cholera, and Polyarteritis Nodosa (PAN).
Explanation: **Giardiasis** is caused by the protozoan *Giardia lamblia*, which primarily colonizes the duodenum and upper jejunum [1]. The parasite attaches to the intestinal mucosa via a ventral sucking disc, leading to the blunting of villi and functional malabsorption. The hallmark clinical presentation includes **foul-smelling, frothy, greasy stools (steatorrhea)** that float in water, accompanied by abdominal bloating, flatulence, and weight loss. The "frothy" nature is due to excess gas produced by bacterial fermentation of unabsorbed nutrients. **Why other options are incorrect:** * **Amoebiasis:** Caused by *Entamoeba histolytica*, it typically presents with bloody diarrhea (dysentery), tenesmus, and "anchovy sauce" liver abscesses [2]. It involves the colon rather than the small intestine, so fat malabsorption is not a feature. * **Bacillary dysentery:** Caused by *Shigella*, it presents with high-grade fever, severe abdominal cramps, and small-volume stools containing blood and mucus (inflammatory diarrhea), not malabsorptive stools. * **Pancreatic enzyme deficiency:** While this causes steatorrhea and fat malabsorption [3], it is usually a chronic condition (e.g., Chronic Pancreatitis) associated with deep-seated epigastric pain radiating to the back and history of alcohol use. In the context of standard NEET-PG questions, "frothy stools" is a classic buzzword for Giardiasis. **Clinical Pearls for NEET-PG:** * **Diagnosis:** Stool microscopy (Trophozoites with "Owl's eye" appearance or Cysts) or Entero-test (String test). * **Drug of Choice:** Tinidazole (single dose) or Metronidazole. * **Association:** Common in patients with **IgA deficiency**. * **Site:** It does not invade the bloodstream; it remains luminal/mucosal [1].
Explanation: **Explanation:** **1. Why 24-hour esophageal pH monitoring is the Gold Standard:** Gastroesophageal Reflux Disease (GERD) is fundamentally defined by the abnormal reflux of gastric contents into the esophagus. The **24-hour ambulatory pH monitoring** is the gold standard because it provides a quantitative assessment of esophageal acid exposure. It measures the percentage of time the pH drops below 4, correlates symptoms with reflux episodes (Symptom Index), and calculates the **DeMeester Score**. It is particularly essential for patients with persistent symptoms despite PPI therapy or those with atypical (extra-esophageal) symptoms. **2. Analysis of Incorrect Options:** * **Upper GI Endoscopy (EGD):** While often the *first-line* investigation to rule out complications (like Barrett’s esophagus or malignancy), it has low sensitivity for GERD. Up to 60-70% of patients have **NERD (Non-Erosive Reflux Disease)**, where the endoscopy appears completely normal. * **Barium Swallow/Meal:** These are useful for identifying structural abnormalities like hiatal hernias, strictures, or achalasia, but they cannot reliably diagnose or quantify acid reflux. **3. High-Yield Clinical Pearls for NEET-PG:** * **Investigation of Choice (Initial):** Upper GI Endoscopy (to check for "red flags" like dysphagia or weight loss). * **Bravo pH Monitoring:** A newer, wireless capsule method that is better tolerated than the transnasal catheter. * **Impedance-pH Monitoring:** The preferred test for detecting **non-acid reflux** (alkaline reflux). * **Treatment of Choice:** Lifestyle modifications + Proton Pump Inhibitors (PPIs). * **Surgical Gold Standard:** Laparoscopic Nissen Fundoplication (360 wrap).
Explanation: **Explanation:** **1. Why Option C is the correct answer (The "False" statement):** In Gluten-Sensitive Enteropathy (Celiac Disease), patients must strictly avoid **BROW**—**B**arley, **R**ye, **O**ats (due to cross-contamination), and **W**heat [1]. However, **Rice and Corn** are gluten-free and are safe alternatives. Therefore, the statement that "rice should be avoided" is incorrect, making Option C the right choice for this "not true" question. **2. Analysis of other options:** * **Option A:** Celiac sprue is the synonymous term for gluten-sensitive enteropathy, characterized by an immune-mediated inflammatory response to gluten in genetically predisposed individuals (HLA-DQ2/DQ8) [1]. * **Option B:** Anti-gliadin antibodies (IgA and IgG) are classic markers, though **Anti-Tissue Transglutaminase (tTG) IgA** is now the preferred screening test due to higher sensitivity and specificity. * **Option D:** While Celiac disease is characterized by villous atrophy and crypt **hyperplasia**, active **cryptitis** (neutrophilic infiltration of the crypts) is a hallmark of Inflammatory Bowel Disease (IBD), not Celiac disease [1]. Thus, the statement that cryptitis does not occur is generally considered true in the context of classic histopathology. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Small intestinal biopsy showing **Villous atrophy, Crypt hyperplasia, and increased Intraepithelial Lymphocytes (IELs).** [1] * **Dermatological Association:** **Dermatitis Herpetiformis** (itchy vesicles on extensors) is highly specific. * **Malignancy Risk:** Long-term untreated Celiac disease increases the risk of **Enteropathy-associated T-cell lymphoma (EATL).** * **Best Screening Test:** IgA anti-tTG. (Note: Always check total IgA levels to rule out selective IgA deficiency).
Explanation: This patient presents with **Autoimmune Atrophic Gastritis (Type A Gastritis)**, a condition frequently associated with other autoimmune disorders like Hashimoto's thyroiditis [2]. ### **Why Option B is Correct** In Autoimmune Atrophic Gastritis, the immune system produces antibodies against **parietal cells** and **intrinsic factor** [2]. Parietal cells are responsible for secreting hydrochloric acid (HCl). Their destruction leads to **achlorhydria** (absence of acid) or severe hypochlorhydria, not excessive acid production. Therefore, Option B is the incorrect feature. ### **Explanation of Other Options** * **Option A (Anti-parietal cell antibodies):** These are present in approximately 90% of patients and are the primary mediators of gland destruction in the fundus and body of the stomach. * **Option C (Endocrine cell hyperplasia):** Due to the lack of acid, the negative feedback loop on G-cells is lost, leading to **hypergastrinemia**. Persistent high gastrin levels stimulate the hyperplasia of Enterochromaffin-like (ECL) cells, which can eventually progress to carcinoid tumors. * **Option D (Vitamin B12 deficiency):** Parietal cell loss results in a deficiency of **Intrinsic Factor**. This leads to Vitamin B12 malabsorption, resulting in Megaloblastic anemia (Pernicious Anemia) and neurological symptoms (Subacute Combined Degeneration) [1]. ### **High-Yield Clinical Pearls for NEET-PG** * **Location:** Type **A** affects the **A**natomical Body/Fundus (spares the antrum). Type **B** is associated with **B**acteria (*H. pylori*) and affects the Antrum. * **Biopsy Findings:** Diffuse mucosal atrophy, loss of rugae, and intestinal metaplasia (increased risk of gastric adenocarcinoma). * **Associated Conditions:** Vitiligo, Type 1 Diabetes, and Addison’s disease (Autoimmune Polyendocrine Syndromes). * **Key Lab Marker:** Elevated serum gastrin levels (secondary to achlorhydria).
Explanation: **Explanation:** Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by transmural inflammation that can affect any part of the gastrointestinal tract from the mouth to the anus. **Why Anorectal Lesions are correct:** Anorectal involvement is a hallmark feature of Crohn’s disease and is rarely seen in Ulcerative Colitis (UC). These lesions include **perianal fistulae, fissures, skin tags, and anorectal abscesses**. They occur due to the transmural nature of the inflammation, which leads to the formation of sinus tracts. Finding perianal disease in a patient with chronic diarrhea strongly points toward CD over UC [1]. **Analysis of Incorrect Options:** * **A. Transverse ulcers:** In Crohn’s disease, ulcers are typically **longitudinal (serpentine)** or aphthous [1]. When longitudinal ulcers intersect with edematous mucosa, it creates the classic "cobblestone appearance." Transverse ulcers are more characteristic of Intestinal Tuberculosis. * **B. Nodularity:** While the mucosa may appear irregular, "nodularity" is a non-specific finding. In the context of IBD, "pseudopolyps" are more common, particularly in UC during the healing phase [1]. * **C. Hypertrophic lesions:** These are not a classic endoscopic description for CD. CD is characterized by strictures (due to fibrosis) and "skip lesions" (areas of normal mucosa between inflamed segments) [1]. **NEET-PG High-Yield Pearls:** * **Distribution:** CD is "mouth to anus" with **rectal sparing**; UC involves the rectum and moves proximally (continuous) [1]. * **Microscopy:** **Non-caseating granulomas** are pathognomonic for CD (seen in 30% of cases). * **Radiology:** Look for the **"String sign of Kantor"** (terminal ileum narrowing) and "Proud flesh" sign [1]. * **Serology:** CD is associated with **ASCA** (Anti-Saccharomyces cerevisiae antibodies), while UC is associated with **p-ANCA**.
Esophageal Disorders
Practice Questions
Peptic Ulcer Disease
Practice Questions
Inflammatory Bowel Disease
Practice Questions
Irritable Bowel Syndrome
Practice Questions
Malabsorption Syndromes
Practice Questions
Pancreatitis (Acute and Chronic)
Practice Questions
Gastrointestinal Bleeding
Practice Questions
Liver Diseases and Cirrhosis
Practice Questions
Viral Hepatitis
Practice Questions
Biliary Tract Disorders
Practice Questions
Gastrointestinal Motility Disorders
Practice Questions
Gastrointestinal Malignancies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free